Zymeworks (ZYME) News Today $11.67 +0.32 (+2.82%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$11.32 -0.35 (-2.96%) As of 05/30/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock ZYME Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Voloridge Investment Management LLC Buys Shares of 43,708 Zymeworks Inc. (NYSE:ZYME)Voloridge Investment Management LLC bought a new stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 43,708 shares of the company's stock, valued at approximately $640,000. VolorMay 31 at 4:10 AM | marketbeat.comZymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To BudgeMay 30 at 4:04 PM | msn.comZymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract CancerMay 30 at 6:00 AM | globenewswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Holdings in Zymeworks Inc. (NYSE:ZYME)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 10.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor oMay 30 at 4:03 AM | marketbeat.com36,000 Shares in Zymeworks Inc. (NYSE:ZYME) Bought by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. acquired a new stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 36,000 shares of the compMay 29 at 5:14 AM | marketbeat.comZymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Zymeworks Inc. (NYSE:ZYME - Get Free Report) have earned an average rating of "Moderate Buy" from the ten ratings firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one hasMay 28, 2025 | marketbeat.comZymeworks Inc. (NYSE:ZYME) Receives Average Rating of "Moderate Buy" from AnalystsMay 27, 2025 | americanbankingnews.comWhat is HC Wainwright's Forecast for Zymeworks Q2 Earnings?Zymeworks Inc. (NYSE:ZYME - Free Report) - Equities research analysts at HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for shares of Zymeworks in a report released on Tuesday, May 20th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.45May 24, 2025 | marketbeat.comZymeworks Inc. (NYSE:ZYME) Shares Acquired by Northern Trust CorpNorthern Trust Corp grew its holdings in Zymeworks Inc. (NYSE:ZYME - Free Report) by 6.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 394,830 shares of the company's stock after buying an additional 23,903 shares duriMay 23, 2025 | marketbeat.comZymeworks (NYSE:ZYME) Research Coverage Started at TD SecuritiesMay 23, 2025 | americanbankingnews.comZymeworks (NYSE:ZYME) Earns Buy Rating from Analysts at TD CowenMay 23, 2025 | americanbankingnews.comZymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical ConferencesMay 22, 2025 | globenewswire.comTD Cowen Initiates Coverage on Zymeworks (NYSE:ZYME)TD Cowen initiated coverage on Zymeworks in a research note on Tuesday. They issued a "buy" rating for the company.May 22, 2025 | marketbeat.comPoint72 Asset Management L.P. Boosts Stock Position in Zymeworks Inc. (NYSE:ZYME)Point72 Asset Management L.P. lifted its holdings in Zymeworks Inc. (NYSE:ZYME - Free Report) by 565.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 330,127 shares of the company's stock after purchasing an additionalMay 22, 2025 | marketbeat.comZymeworks (NYSE:ZYME) Stock Price Up 4.2% After Insider Buying ActivityMay 22, 2025 | americanbankingnews.comZymeworks Inc. Presents Promising Preclinical Data for ZW1528, a Novel Bispecific Antibody Targeting IL-4Rα and IL-33 for Respiratory InflammationMay 21, 2025 | nasdaq.comZymeworks Inc. (NYSE:ZYME) Stake Lessened by Vestal Point Capital LPVestal Point Capital LP lessened its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 69.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,000 shares of the company's stock after selling 430,000 shareMay 21, 2025 | marketbeat.comTD Securities Initiates Coverage of Zymeworks (ZYME) with Buy RecommendationMay 21, 2025 | msn.comTD Cowen Initiates Zymeworks With ‘Buy’, Cites Ziihera’s ‘Blockbuster Potential’ In Biliary Tract Cancer TherapyMay 21, 2025 | msn.comZymeworks Announces Participation in Upcoming Investor ConferencesMay 21, 2025 | globenewswire.comZymeworks Inc.: Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International ConferenceMay 20, 2025 | finanznachrichten.dePolar Asset Management Partners Inc. Buys New Holdings in Zymeworks Inc. (NYSE:ZYME)Polar Asset Management Partners Inc. purchased a new position in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,000 shares of the company's stocMay 20, 2025 | marketbeat.comZymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Acquires 5,919 SharesMay 20, 2025 | insidertrades.comZymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International ConferenceMay 19, 2025 | globenewswire.comZymeworks Inc. (NYSE:ZYME) Shares Sold by Prosight Management LPProsight Management LP reduced its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 10.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 820,000 shares of the company's stock after sellinMay 17, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Has $5.21 Million Position in Zymeworks Inc. (NYSE:ZYME)Jacobs Levy Equity Management Inc. lessened its holdings in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 31.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 356,168 shares of the company's stock after selling 166,472 shares during the period. Jacobs LMay 17, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Buys Shares of 22,800 Zymeworks Inc. (NYSE:ZYME)Schonfeld Strategic Advisors LLC purchased a new stake in Zymeworks Inc. (NYSE:ZYME - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 22,800 shares of the company's stock, valued at approximately $May 15, 2025 | marketbeat.comAnalyst Forecasts For Zymeworks Inc. (NASDAQ:ZYME) Are Surging HigherMay 14, 2025 | finance.yahoo.comZymeworks Inc. (NYSE:ZYME) Shares Sold by Granahan Investment Management LLCGranahan Investment Management LLC lowered its holdings in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 33.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 411,120 shares of the company's stockMay 12, 2025 | marketbeat.comFarallon Capital Management LLC Sells 31,026 Shares of Zymeworks Inc. (NYSE:ZYME)Farallon Capital Management LLC lessened its position in Zymeworks Inc. (NYSE:ZYME - Free Report) by 2.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,329,974 shares of the company's stock after selling 31,026 sharesMay 11, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 123,240 Shares of Zymeworks Inc. (NYSE:ZYME)Dimensional Fund Advisors LP lifted its position in Zymeworks Inc. (NYSE:ZYME - Free Report) by 14.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 972,742 shares of the company's stock after purchaMay 11, 2025 | marketbeat.comZymeworks May 2025 slides: Pipeline expansion amid modest revenue growthMay 10, 2025 | investing.comZymeworks Inc. Reports Financial Results and Highlights Recent Developments, Including Appointment of Dr. Sabeen Mekan and AACR Poster PresentationsMay 10, 2025 | nasdaq.comZymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comZymeworks Inc. (NYSE:ZYME) Shares Bought by Voya Investment Management LLCVoya Investment Management LLC increased its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 207.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 59,514 shares of the company's stock after acquiring an additional 40May 10, 2025 | marketbeat.comZymeworks Inc.: Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial ResultsMay 10, 2025 | finanznachrichten.deZymeworks outlines robust pipeline advancements and financial resilience through 2027May 10, 2025 | msn.comZymeworks Provides Corporate Update and Reports First Quarter 2025 Financial ResultsMay 10, 2025 | finance.yahoo.comZymeworks Inc. (ZYME) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comZymeworks Inc. 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comBlackstone Inc. Has $8.34 Million Stock Position in Zymeworks Inc. (NYSE:ZYME)Blackstone Inc. increased its position in Zymeworks Inc. (NYSE:ZYME - Free Report) by 2,171.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 569,715 shares of the company's stock after buying an additionaMay 8, 2025 | marketbeat.comRaymond James Financial Inc. Takes $888,000 Position in Zymeworks Inc. (NYSE:ZYME)Raymond James Financial Inc. bought a new position in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 60,642 shares of the company's stock, valued at approximatelyMay 8, 2025 | marketbeat.comJazz Pharmaceuticals Stock Price, Quotes and ForecastsMay 7, 2025 | benzinga.comZymeworks Inc. (NYSE:ZYME) Shares Sold by BVF Inc. ILBVF Inc. IL lowered its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,308,935 shares of the company's stock after selling 299,000 shares during tMay 6, 2025 | marketbeat.comAcuta Capital Partners LLC Acquires Shares of 67,240 Zymeworks Inc. (NYSE:ZYME)Acuta Capital Partners LLC purchased a new stake in Zymeworks Inc. (NYSE:ZYME - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 67,240 shares of the company's stock, valued at approximately $984,000. Zymeworks comprises 1.0% of Acuta CapitalMay 4, 2025 | marketbeat.comInvesco Ltd. Reduces Position in Zymeworks Inc. (NYSE:ZYME)Invesco Ltd. reduced its holdings in Zymeworks Inc. (NYSE:ZYME - Free Report) by 57.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,382 shares of the company's stock after sellinMay 4, 2025 | marketbeat.comZymeworks Inc. (NYSE:ZYME) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Zymeworks Inc. (NYSE:ZYME - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, five have issued a buy recommendationMay 4, 2025 | marketbeat.comQ2 Earnings Forecast for Zymeworks Issued By Leerink PartnrsZymeworks Inc. (NYSE:ZYME - Free Report) - Stock analysts at Leerink Partnrs raised their Q2 2025 EPS estimates for Zymeworks in a research report issued on Monday, April 28th. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings per share of ($0.56) for the quarterMay 3, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Purchases New Shares in Zymeworks Inc. (NYSE:ZYME)Susquehanna Fundamental Investments LLC acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 97,553 shares of the company's stock, valued at approximately $1,428,000. SusquehannaMay 3, 2025 | marketbeat.comZymeworks (ZYME) Expected to Announce Earnings on ThursdayZymeworks (NYSE:ZYME) will be releasing earnings after the market closes on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-zymeworks-inc-stock/)May 3, 2025 | marketbeat.com Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address ZYME Media Mentions By Week ZYME Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZYME News Sentiment▼0.800.88▲Average Medical News Sentiment ZYME News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZYME Articles This Week▼76▲ZYME Articles Average Week Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALVO News VKTX News CPRX News MTSR News MOR News SRRK News PTGX News CRNX News MLTX News IMVT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ZYME) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymeworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zymeworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
